Skip to main content
. 2018 Nov 13;12:2413–2424. doi: 10.2147/PPA.S182563

Figure 3.

Figure 3

Migraine-specific HCRU as count of persons with at least one visit (%) (A), and as per 100 patient-years (B) during baseline period and treatment period.

Notes: ^p<0.0001, *p<0.01 for within-group differences from baseline. More statistical comparisons were not performed for the analysis in (A) and for the GMB all group in (B).

Abbreviations: ER, emergency room; GMB, galcanezumab; HCP, health care professional.